130 related articles for article (PubMed ID: 7414013)
1. [Gamma dose estimation to the gastric wall after administration of a capsule containing a large dose of 131I (author's transl)].
Oyamada H; Fukukita H; Kawachi K; Kawai H; Nagaiwa K; Terui S; Ebihara S
Radioisotopes; 1980 May; 29(5):227-32. PubMed ID: 7414013
[TBL] [Abstract][Full Text] [Related]
2. 131-Iodine capsules in thyroid therapy: an individually controlled study of their uptake kinetics as compared to liquid 131-iodine.
von Schulthess GK; Seelentag WW; Pfeiffer G; Blaeuenstein P; Bekier A
Eur J Nucl Med; 1985; 10(1-2):25-8. PubMed ID: 3838513
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose to patients and relatives incident to 131I therapy.
Zanzonico PB
Thyroid; 1997 Apr; 7(2):199-204. PubMed ID: 9133684
[TBL] [Abstract][Full Text] [Related]
4. Decreased uptake after fractionated ablative doses of iodine-131.
Wu HS; Hseu HH; Lin WY; Wang SJ; Liu YC
Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):167-73. PubMed ID: 15351912
[TBL] [Abstract][Full Text] [Related]
5. Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I.
Rini JN; Vallabhajosula S; Zanzonico P; Hurley JR; Becker DV; Goldsmith SJ
Thyroid; 1999 Apr; 9(4):347-52. PubMed ID: 10319939
[TBL] [Abstract][Full Text] [Related]
6. Effective method of measuring the radioactivity of [ 131I]-capsule prior to radioiodine therapy with significant reduction of the radiation exposure to the medical staff.
Lützen U; Zhao Y; Marx M; Imme T; Assam I; Siebert FA; Culman J; Zuhayra M
J Appl Clin Med Phys; 2016 Jul; 17(4):59-72. PubMed ID: 27455475
[TBL] [Abstract][Full Text] [Related]
7. Radioiodine lobar ablation as an alternative to completion thyroidectomy in patients with differentiated thyroid cancer.
Bal CS; Kumar A; Pant GS
Nucl Med Commun; 2003 Feb; 24(2):203-8. PubMed ID: 12548045
[TBL] [Abstract][Full Text] [Related]
8. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.
Ceccarelli C; Battisti P; Gasperi M; Fantuzzi E; Pacini F; Gualdrini G; Pierantoni MC; Luciani A; Djokich D; Pinchera A
J Nucl Med; 1999 Oct; 40(10):1716-21. PubMed ID: 10520714
[TBL] [Abstract][Full Text] [Related]
9. Neck and whole-body scanning with 5-mCi dose of (123)I as diagnostic tracer in patients with well-differentiated thyroid cancer.
Gulzar Z; Jana S; Young I; Bukberg P; Yen V; Naddaf S; Abdel-Dayem HM
Endocr Pract; 2001; 7(4):244-9. PubMed ID: 11497474
[TBL] [Abstract][Full Text] [Related]
10. [The influence of the galenic form of 131I administration on the results of radioiodine tests--comparison of 131I in capsules and in solutions (author's transl)].
Müller-Brand J; Staub JJ; Moeglen C; Peyer P
Nuklearmedizin; 1978 Apr; 17(2):70-3. PubMed ID: 78485
[TBL] [Abstract][Full Text] [Related]
11. The clinical effects of thyroid stunning after diagnostic whole-body scanning with 185 MBq 131I.
Lees W; Mansberg R; Roberts J; Towson J; Chua E; Turtle J
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1421-7. PubMed ID: 12397458
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow dosimetry and safety of high 131I activities given after recombinant human thyroid-stimulating hormone to treat metastatic differentiated thyroid cancer.
de Keizer B; Hoekstra A; Konijnenberg MW; de Vos F; Lambert B; van Rijk PP; Lips CJ; de Klerk JM
J Nucl Med; 2004 Sep; 45(9):1549-54. PubMed ID: 15347723
[TBL] [Abstract][Full Text] [Related]
13. Chronic myeloid leukaemia following 131I treatment for thyroid carcinoma: a report of two cases and review of the literature.
Shimon I; Kneller A; Olchovsky D
Clin Endocrinol (Oxf); 1995 Nov; 43(5):651-4. PubMed ID: 8548952
[TBL] [Abstract][Full Text] [Related]
14. Lithium as an adjuvant in the postoperative ablation of remnant tissue in low-risk thyroid carcinoma.
Yamazaki CA; Padovani RP; Biscolla RP; Ikejiri ES; Marchetti RR; Castiglioni ML; Matsumura LK; Maciel RM; Furlanetto RP
Thyroid; 2012 Oct; 22(10):1002-6. PubMed ID: 22953991
[TBL] [Abstract][Full Text] [Related]
15. Incidence of radiation thyroiditis and thyroid remnant ablation success rates following 1110 MBq (30 mCi) and 3700 MBq (100 mCi) post-surgical 131I ablation therapy for differentiated thyroid carcinoma.
Cherk MH; Kalff V; Yap KS; Bailey M; Topliss D; Kelly MJ
Clin Endocrinol (Oxf); 2008 Dec; 69(6):957-62. PubMed ID: 18419785
[TBL] [Abstract][Full Text] [Related]
16. Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I.
Hilditch TE; Dempsey MF; Bolster AA; McMenemin RM; Reed NS
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):783-8. PubMed ID: 12029552
[TBL] [Abstract][Full Text] [Related]
17. Assessment of the efficacy of iodine-131 for thyroid ablation.
Comtois R; Thériault C; Del Vecchio P
J Nucl Med; 1993 Nov; 34(11):1927-30. PubMed ID: 8229236
[TBL] [Abstract][Full Text] [Related]
18. [A study on the isolation period of patients with metastatic thyroid cancer treated by 131I according to a new guideline].
Tsuchimochi S; Nakajo M; Umanodan T; Fukushima N; Shigaki S; Kiku T
Kaku Igaku; 2001 Nov; 38(6):747-54. PubMed ID: 11806086
[TBL] [Abstract][Full Text] [Related]
19. Failure of low doses of 131I to ablate residual thyroid tissue following surgery for thyroid cancer.
Kuni CC; Klingensmith WC
Radiology; 1980 Dec; 137(3):773-4. PubMed ID: 7444061
[TBL] [Abstract][Full Text] [Related]
20. Thyroid cancer: radiation safety precautions in 131I therapy based on actual biokinetic measurements.
Liu B; Peng W; Huang R; Tian R; Zeng Y; Kuang A
Radiology; 2014 Oct; 273(1):211-9. PubMed ID: 24895877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]